Does BINIMETINIB Cause Metastatic malignant melanoma? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Metastatic malignant melanoma have been filed in association with BINIMETINIB (MEKTOVI). This represents 0.3% of all adverse event reports for BINIMETINIB.
21
Reports of Metastatic malignant melanoma with BINIMETINIB
0.3%
of all BINIMETINIB reports
12
Deaths
9
Hospitalizations
How Dangerous Is Metastatic malignant melanoma From BINIMETINIB?
Of the 21 reports, 12 (57.1%) resulted in death, 9 (42.9%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Metastatic malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BINIMETINIB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Product use in unapproved indication (508)
Pyrexia (490)
Neoplasm progression (387)
Vomiting (375)
Rash (360)
What Other Drugs Cause Metastatic malignant melanoma?
DABRAFENIB (449)
TRAMETINIB DIMETHYL SULFOXIDE (267)
TRAMETINIB (173)
SILDENAFIL (116)
TALIMOGENE LAHERPAREPVEC (109)
NIVOLUMAB (87)
PREDNISONE (77)
PEMBROLIZUMAB (74)
TADALAFIL (71)
IPILIMUMAB (69)
Which BINIMETINIB Alternatives Have Lower Metastatic malignant melanoma Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL